Report Detail
Global Lanreotide Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4742291 |
- 28 September, 2026 |
- Global |
- 78 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Lanreotide Injection market size was valued at US$ 538 million in 2025 and is forecast to a readjusted size of US$ 706 million by 2032 with a CAGR of 4.0% during review period.
Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes TSH. Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.
This report is a detailed and comprehensive analysis for global Lanreotide Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lanreotide Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Lanreotide Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Lanreotide Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Lanreotide Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lanreotide Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lanreotide Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ipsen, Cipla, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Lanreotide Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sustained Release Formulation
Long-acting Formula
Market segment by Application
Hospital
Clinic
Others
Major players covered
Ipsen
Cipla
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lanreotide Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lanreotide Injection, with price, sales quantity, revenue, and global market share of Lanreotide Injection from 2021 to 2026.
Chapter 3, the Lanreotide Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lanreotide Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Lanreotide Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lanreotide Injection.
Chapter 14 and 15, to describe Lanreotide Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Lanreotide Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Sustained Release Formulation
- 1.3.3 Long-acting Formula
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Lanreotide Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Lanreotide Injection Market Size & Forecast
- 1.5.1 Global Lanreotide Injection Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Lanreotide Injection Sales Quantity (2021-2032)
- 1.5.3 Global Lanreotide Injection Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Ipsen
- 2.1.1 Ipsen Details
- 2.1.2 Ipsen Major Business
- 2.1.3 Ipsen Lanreotide Injection Product and Services
- 2.1.4 Ipsen Lanreotide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Ipsen Recent Developments/Updates
- 2.2 Cipla
- 2.2.1 Cipla Details
- 2.2.2 Cipla Major Business
- 2.2.3 Cipla Lanreotide Injection Product and Services
- 2.2.4 Cipla Lanreotide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Cipla Recent Developments/Updates
3 Competitive Environment: Lanreotide Injection by Manufacturer
- 3.1 Global Lanreotide Injection Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Lanreotide Injection Revenue by Manufacturer (2021-2026)
- 3.3 Global Lanreotide Injection Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Lanreotide Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Lanreotide Injection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Lanreotide Injection Manufacturer Market Share in 2025
- 3.5 Lanreotide Injection Market: Overall Company Footprint Analysis
- 3.5.1 Lanreotide Injection Market: Region Footprint
- 3.5.2 Lanreotide Injection Market: Company Product Type Footprint
- 3.5.3 Lanreotide Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Lanreotide Injection Market Size by Region
- 4.1.1 Global Lanreotide Injection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Lanreotide Injection Consumption Value by Region (2021-2032)
- 4.1.3 Global Lanreotide Injection Average Price by Region (2021-2032)
- 4.2 North America Lanreotide Injection Consumption Value (2021-2032)
- 4.3 Europe Lanreotide Injection Consumption Value (2021-2032)
- 4.4 Asia-Pacific Lanreotide Injection Consumption Value (2021-2032)
- 4.5 South America Lanreotide Injection Consumption Value (2021-2032)
- 4.6 Middle East & Africa Lanreotide Injection Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Lanreotide Injection Sales Quantity by Type (2021-2032)
- 5.2 Global Lanreotide Injection Consumption Value by Type (2021-2032)
- 5.3 Global Lanreotide Injection Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Lanreotide Injection Sales Quantity by Application (2021-2032)
- 6.2 Global Lanreotide Injection Consumption Value by Application (2021-2032)
- 6.3 Global Lanreotide Injection Average Price by Application (2021-2032)
7 North America
- 7.1 North America Lanreotide Injection Sales Quantity by Type (2021-2032)
- 7.2 North America Lanreotide Injection Sales Quantity by Application (2021-2032)
- 7.3 North America Lanreotide Injection Market Size by Country
- 7.3.1 North America Lanreotide Injection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Lanreotide Injection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Lanreotide Injection Sales Quantity by Type (2021-2032)
- 8.2 Europe Lanreotide Injection Sales Quantity by Application (2021-2032)
- 8.3 Europe Lanreotide Injection Market Size by Country
- 8.3.1 Europe Lanreotide Injection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Lanreotide Injection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Lanreotide Injection Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Lanreotide Injection Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Lanreotide Injection Market Size by Region
- 9.3.1 Asia-Pacific Lanreotide Injection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Lanreotide Injection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Lanreotide Injection Sales Quantity by Type (2021-2032)
- 10.2 South America Lanreotide Injection Sales Quantity by Application (2021-2032)
- 10.3 South America Lanreotide Injection Market Size by Country
- 10.3.1 South America Lanreotide Injection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Lanreotide Injection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Lanreotide Injection Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Lanreotide Injection Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Lanreotide Injection Market Size by Country
- 11.3.1 Middle East & Africa Lanreotide Injection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Lanreotide Injection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Lanreotide Injection Market Drivers
- 12.2 Lanreotide Injection Market Restraints
- 12.3 Lanreotide Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Lanreotide Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Lanreotide Injection
- 13.3 Lanreotide Injection Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Lanreotide Injection Typical Distributors
- 14.3 Lanreotide Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Lanreotide Injection. Industry analysis & Market Report on Lanreotide Injection is a syndicated market report, published as Global Lanreotide Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Lanreotide Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
